DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Glucovance (Glyburide / Metformin) - Adverse Event Reports - Other Serious Reactions - Dyspnoea

 



Index of reports > Cases resulting in other serious reactions (6) > Cases with Dyspnoea (2)

Below is the selection of adverse event reports related to Glucovance (Glyburide / Metformin) that includes cases resulting in other serious reactions where reactions include dyspnoea.

Adverse event in 55 year old female receiving Glucovance (Glyburide / Metformin)

Reported by a consumer/non-health professional from United States on 2007-06-27

Patient: 55 year old female, weighing 148.0 kg (325.6 pounds)

Adverse reactions / side effects: Weight Increased, Blood Glucose Decreased, Dyspnoea, Oedema Peripheral, Hypoglycaemia, Pulmonary Oedema, Hypoxia, Cardiac Failure Congestive

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Avandia
    Dosage: 4mg twice per day
    Administration route: Oral

Glucovance

Other drugs received by patient: Lisinopril; Aspirin; Celexa; Gabapentin



Adverse event in 55 year old female receiving Glucovance (Glyburide / Metformin)

Reported by a consumer/non-health professional from United States on 2007-06-21

Patient: 55 year old female, weighing 148.0 kg (325.6 pounds)

Adverse reactions / side effects: Weight Increased, Blood Glucose Decreased, Dyspnoea, Oedema Peripheral, Hypoglycaemia, Pulmonary Oedema, Hypoxia, Cardiac Failure Congestive

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Avandia
    Dosage: 4mg twice per day
    Administration route: Oral
    Indication: Diabetes Mellitus non-Insulin-Dependent

Glucovance

Other drugs received by patient: Lisinopril; Aspirin; Celexa; Gabapentin

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009